HLA
BiomarkerHLA Typing
Human leukocyte antigen (HLA) genes regulate immune recognition. Specific HLA types are required for eligibility for certain cell-based and immune therapies.
Approvals
2
Indications
2
Therapies
2
Mapped tests
1
Where this biomarker is used
Each approval combines this biomarker with a specific indication and therapy. Select a therapy in the tables below to open its FDA-defined testing pathway.
Indication-specific approvals
Approvals where HLA is defined directly in the indication labeling.
Tumor-agnostic approvals
Approvals defined at the solid tumor level where HLA is part of the eligibility criteria.
No tumor-agnostic approvals are currently mapped for this biomarker.
Tests that measure this biomarker
These assays report HLA as part of their validated menu. In many cases they are identified in FDA labeling as acceptable companion diagnostics for specific approvals.
Test
SeCore CDx HLA Sequencing System
One Lambda, Inc.
Method
SANGER
Specimen
Whole blood
Reports HLA as part of its biomarker panel.
2 approvalsView test profile →